Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy-Reference-Cited by-同舟云学术

Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy

Published:2017-03-13 Issue:2 Volume:361 Page:303-311
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Salatto Christopher T.,Miller Russell A.,Cameron Kimberly O.,Cokorinos Emily,Reyes Allan,Ward Jessica,Calabrese Matthew F.,Kurumbail Ravi G.,Rajamohan Francis,Kalgutkar Amit S.,Tess David A.,Shavnya Andre,Genung Nathan E.,Edmonds David J.,Jatkar Aditi,Maciejewski Benjamin S,Amaro Marina,Gandhok Harmeet,Monetti Mara,Cialdea Katherine,Bollinger Eliza,Kreeger John M.,Coskran Timothy M.,Opsahl Alan C.,Boucher Germaine G.,Birnbaum Morris J.,DaSilva-Jardine Paul,Rolph Tim

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference24 articles.

1. Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats

2. Refinement of severely incomplete structures with maximum likelihood inBUSTER–TNT

3. A Soluble Guanylate Cyclase Activator Inhibits the Progression of Diabetic Nephropathy in the ZSF1 Rat

4. Structural Basis for AMPK Activation: Natural and Synthetic Ligands Regulate Kinase Activity from Opposite Poles by Different Molecular Mechanisms

5. Discovery and preclinical characterization of 6-chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic acid (PF-06409577), a direct activator of adenosine monophosphate-activated protein kinase (AMPK), for the potential treatment of diabetic nephropathy;Cameron;J Med Chem,2016

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the ferroptosis pathways in dorsal root ganglia of Friedreich ataxia models. The role of LKB1/AMPK, KEAP1, and GSK3β in the impairment of the NRF2 response;Redox Biology;2024-10

2. Mitochondrial UCP1: Potential thermogenic mechanistic switch for the treatment of obesity and neurodegenerative diseases using natural and epigenetic drug candidates;Phytomedicine;2024-07

3. The interplay between mitochondrial dysfunction and NLRP3 inflammasome in multiple sclerosis: Therapeutic implications and animal model studies;Biomedicine & Pharmacotherapy;2024-06

4. AMPK pathway: an emerging target to control diabetes mellitus and its related complications;Journal of Diabetes & Metabolic Disorders;2024-04-18

5. The AMPK-Sirtuin 1-YAP axis is regulated by fluid flow intensity and controls autophagy flux in kidney epithelial cells;Nature Communications;2023-12-05